Jingrong Jean Cui, Director at Turning Point Therapeutics, Inc. (TPTX), sold 48,084 shares at $37.88 ($2.1M) on 2020-03-23, disclosed to the SEC on 2020-03-25.
Open-market sale of $2.1M TPTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.52 | 900 | $33K | 1.6% |
| 2 | $37.88 | 1,900 | $72K | 3.4% |
| 3 | $38.77 | 3,000 | $116K | 5.6% |
| 4 | $38.77 | 3,000 | $116K | 5.6% |
| 5 | $39.63 | 1,200 | $48K | 2.3% |
| 6 | $40.75 | 1,300 |
| $53K |
| 2.5% |
| 7 | $41.73 | 3,200 | $134K | 6.4% |
| 8 | $42.72 | 2,100 | $90K | 4.3% |
| 9 | $43.58 | 400 | $17K | 0.8% |
| 10 | $44.56 | 2,100 | $94K | 4.5% |
| 11 | $45.35 | 13,292 | $603K | 28.8% |
| 12 | $45.35 | 13,292 | $603K | 28.8% |
| 13 | $46.50 | 2,200 | $102K | 4.9% |
| 14 | $47.11 | 200 | $9K | 0.5% |
| Total | $43.46 avg | 48,084 | $2.1M | 100% |
| Filing → |
| TPTX | SELL | 2020-05-21 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-12 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-07 | $5.8M | — | Filing → |